Workflow
Biofuels policy
icon
Search documents
Bunge SA(BG) - 2025 Q1 - Earnings Call Transcript
2025-05-07 13:00
Financial Data and Key Metrics Changes - The reported first quarter earnings per share (EPS) was $1.48, down from $1.68 in the first quarter of 2024, with adjusted EPS at $1.81 compared to $3.04 in the prior year [10][12] - Adjusted segment earnings before interest and taxes (EBIT) was $406 million in the quarter, down from $719 million last year [10][12] - The trailing twelve months adjusted return on invested capital (ROIC) was 9.4%, with an adjusted leverage ratio of 0.6 times at the end of the quarter [16] Business Line Data and Key Metrics Changes - Processing results improved in Brazil, Europe, and Asia, but were offset by lower results in North America, Argentina, and European soft seeds [10][12] - Merchandising performance improved in the Global Grains Financial Services business, but was offset by lower results in ocean freight [10][12] - Refined and specialty oils results were down in all regions except Asia, reflecting a more balanced global supply and demand environment [11] Market Data and Key Metrics Changes - The company expects full-year 2025 adjusted EPS of approximately $7.75, which excludes the impact of announced acquisitions and divestitures [18][19] - Agribusiness full-year results are forecasted to be slightly lower than previous outlooks, primarily due to lower results in processing [19] - The company anticipates a favorable outlook for North American canola and a tighter crop in Europe and the Black Sea, which may improve margins [36][37] Company Strategy and Development Direction - The company is focused on closing the transaction with Viterra, which is expected to enhance diversification across assets, geographies, and crops [4][23] - The recent partnership with Repsol aims to create alternative paths towards meeting customer demand for lower carbon agricultural and oil supply chains [6][52] - The company is committed to navigating market uncertainties and believes in the strength of its global infrastructure to ensure efficient supply [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute despite current market challenges and reaffirmed the full-year adjusted EPS guidance [7][21] - The management highlighted the importance of a resilient supply chain to serve key demand markets globally amid market disruptions [30] - The company is optimistic about the potential for improved margins in the second half of the year, particularly in North America [55] Other Important Information - The company terminated the definitive share purchase agreement with CJ Selecta due to regulatory approval delays, but remains optimistic about the soy protein concentrate market [5][31] - The company generated $392 million of adjusted funds from operations in the first quarter, with $338 million of discretionary cash flow available after capital expenditures [13][14] Q&A Session Summary Question: Update on Vitera acquisition approval - Management remains confident in the strategic merits of the Vitera transaction and believes regulatory approval is imminent, with constructive interactions ongoing [29][30] Question: Processing business margins - Margins for U.S. soy and Canadian canola were better in Q1, but are expected to soften in Q2 due to market conditions [33][35] Question: Earnings cadence for the year - The earnings distribution is expected to shift to 60% in the first half and 40% in the second half, with some earnings pulled forward from Q2 to Q1 [42][44] Question: Impact of RVO on margins - A higher Renewable Volume Obligation (RVO) would strengthen the oil leg of the crush in North America, benefiting margins [54][55] Question: South America farmer selling trends - There has been a recent pickup in farmer selling in Argentina, which is expected to positively impact global crush margins [72][73] Question: Timeline for corn milling business closure - The company anticipates closing the corn milling transaction by the end of Q2 or early Q3, pending regulatory processes [110]